- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03902210
BMT Online Wellness Study
An Online Wellness Intervention for Bone Marrow Transplant Survivors
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Online Yoga Group: The intervention will be 12-weeks in duration and will consist of a series of pre-approved online yoga classes (6 manufactured specifically for the cancer-afflicted patients instructed by Udaya yoga therapist, Jules Mitchell, MS). Patients will be asked to complete a minimum of 60 minutes per week of yoga practice with encouragement to do more if they can. All Udaya.com videos will include a proper warm-up, cool down, and closing mindfulness activity (i.e., message from yoga therapist, brief meditation, final relaxation). Qualified Udaya yoga instructors who collectively have over 200 years of training and experience will expertly instruct the online yoga classes. Participants will be instructed to view a safety handout (see yoga safety & modifications handout) before gaining access to the Udaya video library. Yoga therapist, Jules Mitchell and PIs Huberty and Palmer will pre-approve Udaya videos that are appropriate for this population.
A 12-week yoga prescription utilized in previous online yoga studies in MPN patients will be used in the proposed study for BMT patients. The 12-week yoga prescription was designed to be safe and progressive for cancer patients. During the intervention, all classes will offer alternative poses, modifications, and use of props (i.e., yoga blocks and straps) in the instance poses are difficult for the participant (i.e., painful, irregular, uneven breath) and to ensure safety. In addition to specific instruction regarding form and safety, the yoga therapist will provide descriptions of each video that includes tips and modifications to poses (e.g., set the knee on your yoga mat if this feels more comfortable for you). Additionally, patients will also receive a yoga modifications handout outlining the contraindicated yoga poses with modifications (see yoga safety & modifications handout). This handout will include an exercise warning for patients that experience dizziness, lightheadedness or faintness, excessive shortness of breath, chest pain, and that they need to stop the activity and contact their health care professional immediately if these symptoms are experienced.
The participants will access their yoga prescription on the Udaya.com website using their provided username and password (see instruction document). Participants will be asked to participate in a total of at least 60 minutes of yoga and keep a log of their participation utilizing a daily log available through a REDCap link (see yoga group weekly log). For the entire study, participants will record in their log each time they participate in yoga, the class in which they participated, how long they practiced (start and stop time), their perceived exertion, and their perceived mindfulness. Research staff will provide a weekly reminder email at the beginning of each week encouraging participation in their weekly yoga (see weekly reminder emails). We will ask that participants follow the yoga prescription, but if participants feel they want to deviate from the prescription they have the option to participate in any videos assigned in previous weeks or in any of the additional videos included each week in the prescription.
Podcast Control Group: The podcast control group will be asked to view 60 minutes per week of online podcast videos. The podcast videos will contain general cancer-related health education material. To match the online yoga group for time and attention, 60 minutes per week will be prescribed, however, participants will have the ability to view additional videos each week. Furthermore, participants will also track their podcast video viewing each week in a daily log (see podcast group weekly log) by recording each time they view a video, the video that they viewed, and how long they viewed the video.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Arizona
-
Phoenix, Arizona, United States, 86004
- Arizona State University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 1) have received a bone marrow transplant 6 months ago
- 2) have a cancer diagnosis
- 3) no active infections
- 4) platelet count >50
- 5) answer "no" to all items on the Physical Activity Readiness Questionnaire (PAR-Q), or be willing to obtain a signed medical release from their physician in the case that a question is answered with a "yes"
- 6) have access to a desktop or laptop on a regular basis
- 7) have access to reliable internet
- 8) read and understand English
- 9) age 18 years or older
- 10) willing to be randomized to one of two groups
Exclusion Criteria:
- 1) Engagement in yoga in the past year
- 2) currently engage in ≥150 min/week of moderate-/vigorous-intensity physical activity on a weekly basis
- 3) have a history of syncope in last 2 months
- 4) have a history of recurrent falls (≥2 in 2 months)
- 5) Any planned change in pharmacologic intervention (i.e., new drug) during the study interval (i.e., 20 weeks)
- 6) have an Eastern Cooperative Oncology Group 3 (ECOG 3) questionnaire score greater than three
- 7) currently utilize Udaya.com
- 8) currently pregnant
- 9) currently reside outside of the United States of America
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Online Yoga
The intervention will be 12-weeks in duration and will consist of a series of pre-approved online yoga classes (6 manufactured specifically for the cancer-afflicted patients instructed by Udaya yoga therapist, Jules Mitchell, MS).
Patients will be asked to complete a minimum of 60 minutes per week of yoga practice with encouragement to do more if they can.
All Udaya.com
videos will include a proper warm-up, cool down, and closing mindfulness activity (i.e., message from yoga therapist, brief meditation, final relaxation).
Qualified Udaya yoga instructors who collectively have over 200 years of training and experience will expertly instruct the online yoga classes.
Participants will be instructed to view a safety handout (see yoga safety & modifications handout) before gaining access to the Udaya video library.
Yoga therapist, Jules Mitchell and PIs Huberty and Palmer will pre-approve Udaya videos that are appropriate for this population.
|
60 minutes per week of online yoga through Udaya.com
|
Placebo Comparator: Podcast
The podcast control group will be asked to view 60 minutes per week of online podcast videos.
The podcast videos will contain general cancer-related health education material.
To match the online yoga group for time and attention, 60 minutes per week will be prescribed, however, participants will have the ability to view additional videos each week.
Furthermore, participants will also track their podcast video viewing each week in a daily log (see podcast group weekly log) by recording each time they view a video, the video that they viewed, and how long they viewed the video.
|
60 minutes per week of podcasts
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical Function
Time Frame: Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
This measure is captured through the PROMIS-29 Physical Function Subscale.
Raw scores can range from 4-20, with higher scores indicating better physical function.
|
Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
Anxiety
Time Frame: Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
This measure is captured through the PROMIS-29 Anxiety Subscale.
Raw scores range from 4-20, with higher scores indicating more anxiety.
|
Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
Depression
Time Frame: Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
This measure is captured through the PROMIS-29 Depression Subscale.
Raw scores range from 4-20, with higher scores indicating more depression.
|
Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
Fatigue
Time Frame: Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
This measure is captured through the PROMIS-29 Fatigue Subscale.
Raw scores range from 4-20, with higher scores indicating more fatigue.
|
Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
Sleep Disturbance
Time Frame: Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
This measure is captured through the PROMIS-29 Sleep Disturbance Subscale.
Raw scores range from 4-20, with higher scores indicating more sleep disturbance.
|
Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
Ability to Participate in Social Roles and Activities
Time Frame: Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
This measure is captured through the PROMIS-29 Ability to Participate in Social Roles and Activities Subscale.
Raw scores range from 4-20, with higher scores indicating a better ability to participate in social roles and activities.
|
Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
Pain Interference
Time Frame: Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
This measure is captured through the PROMIS-29 Pain Interference Subscale.
Raw scores range from 4-20, with higher scores indicating more interference of pain in daily life.
|
Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
Pain Intensity
Time Frame: Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
This measure is captured through the PROMIS-29 Pain Intensity Subscale.
This is a single-item question asking the participant to rate their average level of pain on a 0-10 scale, with a higher score indicating worse pain.
|
Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
Physical Health
Time Frame: Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
This measure is captured through the PROMIS Global Health Physical Subscale.
Raw scores range from 2-10, with higher scores indicating better physical health.
|
Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
Chronic Graft vs. Host Disease Symptoms
Time Frame: Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
This measure is captured with the Lee Symptom Score, which assesses various symptoms commonly associated with Graft vs. Host Disease.
Raw scores range from 0-120, with higher scores indicating higher symptom burden.
|
Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
Mental Health
Time Frame: Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
This measure is captured through the PROMIS Global Health Mental Health Subscale.
Raw scores range from 2-10, with higher scores indicating better mental health.
|
Change from baseline to midpoint (week 6), post-intervention (week 12), and follow-up (week 20)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Objective Physical Activity
Time Frame: Daily physical activity throughout the 12-week intervention (baseline through week 12)
|
Objective physical activity will be collected with the Fitbit Flex 2 device.
This device captures light, moderate, and vigorous-intensity activity via an accelerometer.
|
Daily physical activity throughout the 12-week intervention (baseline through week 12)
|
Subjective Physical Activity
Time Frame: Weekly physical activity throughout the 12-week intervention (baseline through week 12)
|
Subjective physical activity will be assessed with the Modifiable Activity Questionnaire.
This questionnaire asks participants to indicate the days and the durations in which they participated in 39 different activities.
Weekly minutes of activity is calculated from the information provided.
|
Weekly physical activity throughout the 12-week intervention (baseline through week 12)
|
Objective Yoga/Podcast Participation
Time Frame: Weekly throughout the 12-week intervention (baseline through week 12)
|
Participation in yoga or podcasts is collected through the number of minutes spent viewing/watching/listening to the yoga videos and podcast sessions.
|
Weekly throughout the 12-week intervention (baseline through week 12)
|
Subjective Yoga/Podcast Participation
Time Frame: Weekly throughout the 12-week intervention (baseline through week 12)
|
Participation in yoga or podcasts is collected through self-report yoga or podcast logs.
|
Weekly throughout the 12-week intervention (baseline through week 12)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jennifer Huberty, Ph, Arizona State University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- STUDY00009352
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bone Marrow Transplant
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Duke UniversityCompletedBone Marrow Transplant
-
University of Colorado, DenverGlaxoSmithKlineRecruitingStem Cell Transplant | Bone Marrow TransplantUnited States
-
University of UtahEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedBone Marrow TransplantUnited States
-
Mayo ClinicCompletedStem Cell Transplant | Immunosuppression | Bone Marrow TransplantUnited States
-
Stanford UniversityNational Institutes of Health (NIH)WithdrawnBone Marrow Transplant | Hematopoietic Stem Cell Transplant
-
Nationwide Children's HospitalColumbia UniversityNot yet recruiting
-
University of Colorado, DenverReimagine CareCompletedBone Marrow TransplantUnited States
-
Stanford UniversityCompletedBone Marrow Transplant | Advance DirectivesUnited States
-
St. Jude Children's Research HospitalCompletedStem Cell Transplant | Bone MarrowUnited States, Canada
-
Children's Hospital Medical Center, CincinnatiAstellas Pharma IncTerminatedCancer | Immunocompromised | Bone Marrow TransplantUnited States
Clinical Trials on Online Yoga
-
Arizona State UniversityCompletedDepression | Anxiety | Post-traumatic Stress Disorder | StillbirthUnited States
-
Massachusetts General HospitalMedical University of South Carolina; Brown University; Wake Forest University... and other collaboratorsRecruiting
-
University of BernRecruiting
-
Marmara UniversityCompletedTelerehabilitation | Yoga | Mind-Body TherapiesTurkey
-
Arizona State UniversityNational Institutes of Health (NIH); National Center for Complementary and...Completed
-
Children's Hospital of Eastern OntarioThe Hospital for Sick Children; University of Ottawa; Université de MontréalUnknownPain | Juvenile Idiopathic ArthritisCanada
-
York UniversityCompletedAn Online CBT, Mindfulness Meditation & Yoga (CBT-MY) Intervention for Posttraumatic Stress DisorderPTSD | Posttraumatic Stress DisordersCanada
-
Fertility Centers of IllinoisRush University Medical Center; Pulling Down the Moon, Holistic HealthUnknownAnxiety | Infertility, FemaleUnited States
-
Arizona State UniversityMayo ClinicCompletedQuality of Life | Cancer
-
Universität Duisburg-EssenCompleted